Development of New Prenatal Diagnostic Tests From Maternal Blood
Not Applicable
Terminated
- Conditions
- Hereditary Diseases
- Registration Number
- NCT00314691
- Lead Sponsor
- University Hospital, Strasbourg, France
- Brief Summary
After extraction of the cell-free DNA circulating in maternal plasma, we aim at developing new techniques for fetal DNA enrichment to perform fetal gender determination, and indirect diagnosis of inherited diseases like Cystic Fibrosis, Huntington Disease, Myotonic Dystrophy, B-Thalassaemia...
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
- Mother and father-to-be both older than 18 years old
- Mother and father-to-be affiliated to social security
- Mother and father-to-be have good understanding of the protocol
- Pregnancy of the mother-to-be attested
Exclusion Criteria
- Mother and father-to-be are younger than 18 years old
- Mother and/or father-to be refusing to participate
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Feasibility of fetal gender and genotype determination out of maternal blood
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Sihcus-Cmco
🇫🇷Strasbourg, Schiltigheim, France